Elevated BCRP expression is often associated with poor prognosis in cancer patients. It is linked to aggressive tumor behavior, increased metastatic potential, and reduced survival rates. Assessing BCRP expression levels can serve as a prognostic marker, helping clinicians tailor treatment strategies and predict patient outcomes.
